Your browser doesn't support javascript.
loading
Use of Singing for Lung Health as an alternative training modality within pulmonary rehabilitation for COPD: a randomised controlled trial.
Kaasgaard, Mette; Rasmussen, Daniel Bech; Andreasson, Karen Hjerrild; Hilberg, Ole; Løkke, Anders; Vuust, Peter; Bodtger, Uffe.
Afiliação
  • Kaasgaard M; Pulmonary Research Unit Region Zealand (PLUZ), Dept of Respiratory Medicine, Zealand University Hospital, Naestved, Denmark mk@clin.au.dk.
  • Rasmussen DB; Dept of Clinical Medicine, Center for Music in the Brain, Aarhus University, Denmark and the Royal Academy of Music, Aarhus/Aalborg, Denmark.
  • Andreasson KH; Pulmonary Research Unit Region Zealand (PLUZ), Dept of Respiratory Medicine, Zealand University Hospital, Naestved, Denmark.
  • Hilberg O; Dept of Regional Health Research, University of Southern Denmark, Odense, Denmark.
  • Løkke A; Pulmonary Research Unit Region Zealand (PLUZ), Dept of Respiratory Medicine, Zealand University Hospital, Naestved, Denmark.
  • Vuust P; Dept of Regional Health Research, University of Southern Denmark, Odense, Denmark.
  • Bodtger U; Dept of Physiotherapy and Occupational Therapy, Naestved-Slagelse-Ringsted Hospitals, Naestved, Denmark.
Eur Respir J ; 59(5)2022 05.
Article em En | MEDLINE | ID: mdl-34625480
ABSTRACT

BACKGROUND:

Pulmonary rehabilitation (PR) is a cornerstone in chronic obstructive pulmonary disease (COPD) management. However, PR adherence is generally low, and barriers include availability, economic issues, motivation and an inability to attend or perform physical training. Therefore, alternative, evidence-based PR activities are required. Singing may have benefits for quality of life (QoL), respiratory control and well-being in COPD, but the impact on the PR key outcome, physical exercise capacity, is uncertain.

METHODS:

In this randomised controlled trial (NCT03280355), we investigated the effectiveness of 10 weeks of PR, including either "Singing for Lung Health" (SLH) training or standard physical exercise training (PExT). The primary outcome was a change in exercise capacity (6-min walk distance (6MWD)) from baseline to post-PR. Secondary outcomes were changes in QoL (St George's Respiratory Questionnaire (SGRQ)), Hospital Anxiety and Depression Score (HADS), lung function, dyspnoea and adherence.

RESULTS:

We included 270 COPD patients, and 195 completed the study. Demographics across groups were comparable, and both groups improved significantly in 6MWD and SGRQ score. SLH was non-inferior to PExT in improving 6MWD (mean±sd 13.1±36.3 m versus 14.1±32.3 m, p=0.81; difference 1.0 m, 95% CI -7.3-9.3 m) with 21.8% and 25.0%, respectively (p=0.57), reaching the 6MWD minimal important difference of 30 m. We found no significant between-group differences concerning SGRQ, HADS, lung function, dyspnoea or adherence.

CONCLUSION:

Our study suggests that SLH is non-inferior to PExT in improving 6MWD during a 10-week PR programme. Future studies addressing reproducibility, long-term effects and health economics are needed.
Assuntos

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Doença Pulmonar Obstrutiva Crônica / Canto Tipo de estudo: Clinical_trials Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Eur Respir J Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Doença Pulmonar Obstrutiva Crônica / Canto Tipo de estudo: Clinical_trials Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Eur Respir J Ano de publicação: 2022 Tipo de documento: Article